CVE-2006-5374
Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and...
CVE-2006-5374 is a high vulnerability (CVSS 10.0) in Oracle Pharmaceutical, published October 18, 2006. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 4.16%, the 91st percentile. No source names a fixed version.
- Severity
- 10.0 HighCVSS 2.0, NVD
- Exploit chance
- 4.16%EPSS, 91st percentile
- Exploitation
- None knownNot on CISA’s or ENISA’s lists
- Fixed in
- No fix listedNo source names one
Description
Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
Exploit likelihood
Affected products
What each source reports
NVD Score used
Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
- Record
CVE-2006-5374- CVSS 2.0
- 10.0 High
AV:N/AC:L/Au:N/C:C/I:C/A:C - Updated
- 2026-11-02
CVE ListNo score
Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
- Record
CVE-2006-5374- Updated
- 2026-11-02
EUVDEUVD-2006-5359No score
Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
- Record
EUVD-2006-5359- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-x8jc-rp2j-5v75No score
Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and...
Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
- Record
GHSA-x8jc-rp2j-5v75- Updated
- 2026-11-02
History
| Recorded | Changed | Sources |
|---|---|---|
| facts | ||
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.